Press Release - 1997

Press Release - 1997

  1. You are here:  
  2. Home
  3. Press Release - 1997

Sabinsa Corporation unit receives award from Government of India for developing Garcinia Market

KOCHI, INDIA - Dr. Muhammed Majeed, founder, President and CEO of the Sabinsa Corporation, Piscataway, New Jersey, announced that the company's research and manufacturing branch in India has received national recognition from the Indian government for the company's pioneering role in developing the garcinia market. The unit was applauded for developing the export market for garcinia which is sold by Sabinsa to product manufacturers under the trade name Citrin® , the only garcinia clinically tested in the U.S. and Europe.

The award, given by the Spices Board of India, was presented by India's Commerce Secretary Tejendra Khanna "for outstanding performance for development and export of new products - garcinia cambogia."

In 1995 the company also received the President's Award for Quality and Innovation from Dr. Shankar Dayal Sharma, President of India.

 

    VISIT US

  • Sabinsa Europe GmbH
    Monzastrasse 4
    63225 Langen
    Germany

  • +49 6103 270 11 11
  • +49 6103 270 11 27
  • info@sabinsa.eu

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.